Quanta
Alcester
About Quanta
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10M+
- Total funding: $411.7M
- Funding stage: Late Stage Venture
- Last round: Series E (Nov 2024)
- Website: quantadt.com
- Phone: +44 1789 400043
Industries & Categories
Clinical Trials, Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/quanta-93244 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.